SHH · 600479.SS
ZhuZhou QianJin Pharmaceutical Co.,Ltd
CN¥10.44+CN¥0.20 (+1.95%)
ZhuZhou QianJin Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 31.54% below the high.
Loading market information…
SHZ · 002644.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:04 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
LanZhou Foci Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.12% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
LanZhou Foci Pharmaceutical Co.,Ltd.’s forward annual dividend is CN¥0.24 per share, paid quarterly. The forward yield is 3.26% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow LanZhou Foci Pharmaceutical Co.,Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
LanZhou Foci Pharmaceutical Co.,Ltd. is a prominent pharmaceutical entity based in China, primarily focused on the manufacturing and distribution of traditional Chinese medicines. Its diverse product line, offered under the "Min Shan" and "Foci" brand names, encompasses a variety of formats, including pills, tablets, capsules, and granules. Beyond its production activities, the company actively pursues research and development initiatives aimed at pioneering novel herbal remedies. Its global footprint extends to approximately 27 countries, with key export markets including the United States, Canada, Japan, Australia, Russia, Ukraine, Singapore, Indonesia, Thailand, Malaysia, New Zealand, and Hong Kong. Established in 1929, the firm's headquarters are located in Lanzhou, China. LanZhou Foci Pharmaceutical Co.,Ltd. operates as a subsidiary of the Lanzhou Foci Pharmaceutical Factory.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:21 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥10.44+CN¥0.20 (+1.95%)
ZhuZhou QianJin Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 31.54% below the high.
CN¥7.16+CN¥0.06 (+0.85%)
Yabao Pharmaceutical Group Co., Ltd’s quoted price sits in the upper half of its reported 52-week range, 3.89% below the high.
CN¥8.07+CN¥0.08 (+1.0%)
Beijing Beilu Pharmaceutical Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 29.09% below the high.
CN¥4.55-CN¥0.09 (-1.94%)
Jinhe Biotechnology Co. Ltd.’s quoted price sits in the lower half of its reported 52-week range, 35.0% below the high.
CN¥5.90+CN¥0.02 (+0.34%)
Jinling Pharmaceutical Company Limited’s quoted price sits in the lower half of its reported 52-week range, 39.8% below the high.
CN¥8.37CN¥0.00 (0.0%)
Tibet Weixinkang Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 29.55% below the high.
CN¥7.94-CN¥0.08 (-1.0%)
Zhejiang Starry Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 44.75% below the high.
CN¥9.84-CN¥0.10 (-1.01%)
Harbin Medisan Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 44.9% below the high.
